The evidence that has been obtained, mainly in the last 12 years, for the presence of cell-mediated immunity to muscle in patients with polymyositis and myasthenia gravis is reviewed. The significance of this factor in the etiology of these diseases is discussed. Reference is made to the experimental counterparts in animals.
The histological pathology of polymyositis strongly suggests the possibility of a cell-mediated immune disease. There is mononuclear inflammatory cell infiltration, segmental necrosis of muscle fibres and evidence of regeneration. An autoimmune etiology in polymyositis is also in-,dicated by favourable response to steroid therapy and the overlap with other autoimmune diseases, which are mostly of the nonorgan specific type; systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritis in particular.
In myasthenia gravis the muscles usually appear histologically normal except in longstanding cases when there may be evidence of denervation atrophy of muscle fibres (Brownell et al. 1972) . Small groups of mononuclear inflammatory cells may be seen in the interstitial connective tissue. The electron microscope shows the motor end plates to be damaged. The normally close apposition between the presynaptic and postsynaptic surfaces is lost, the secondary synaptic clefts are shallower, widened and more disorganized than in a normal end plate, and the basement membrane is irregular and reduplicated (Santa et al. 1972 ). An autoimmune etiology is indicated in myasthenia gravis by the involvement of the thymus, with the presence of pathological changes in 75 % of these patients, hyperplasia in 66 % and a thymoma in 9 % (Namba et al. 1976 ); the fact that immunosuppressive drugs are of value in treatment and thymectomy may be beneficial; and overlap with other autoimmune diseases, particularly of the thyroid (Simpson 1969 ).
Polymyositis
Studies of cellular immunity in polymyositis have been carried out to determine whether or not there is sensitization of lymphocytes to homogenized skeletal muscle and various fractions of it. The first method used was that of lymphocyte transformation by Saunders et al. (1969) and later by Esiri et al. (1973) who showed that the amount of lymphocyte stimulation by skeletal muscle was related to the activity of the disease at the time of testing, and was reduced after the commencement of treatment with steroids. The other methods used have been macrophage migration inhibition factor production (Goust et al. 1974 ) and demonstration of lymphotoxin production when lymphocytes were incubated with muscle, or when a muscle biopsy containing lymphocytes was incubated alone (Johnson et al. 1972 ). In addition there have been several studies of lymphocyte cytotoxicity for cultured skeletal muscle, demonstrating specific cytotoxicity of lymphocytes from patients with polymyositis. These studies have utilized various methods of assessing damage to the cultured muscle, the early studies using microscopy (Currie et al. 1971 ) and more recent ones radioactive chromium release (Dawkins & Mastaglia 1973) and release of the muscle enzyme creatine phosphokinase (Haas & Arnason 1974) . Another model used has demonstrated specific immune adherence of lymphocytes from patients with polymyositis to cultured skeletal muscle fibres (Smith et al. 1977) .
Despite this success in demonstrating significant sensitization of lymphocytes from patients with polymyositis to skeletal muscle, there is some overlap in the results from patients and controls. Therefore, confident diagnosis of this disease on the basis of lymphocyte studies alone, dispensing with the need for a muscle biopsy, is not possible. This might become possible if the antigen or antigens to which the lymphocytes respond could be more precisely identified and purified.
Experimental Myositis An animal model of myositis was first described by Pearson (1956) and subsequently by many other workers (Dawkins 1965 , Kakulas 1966 , Parkes 1966 , Takayanagi 1967 , Currie et al. 1971 , Dawkins et al. 1971 , Kalden et al. 1973 , Morgan et al. 1971 , Esiri & MacLennan 1974 , Manghani et al. 1974 ). Focal lesions have been produced in rats and guinea pigs by the injection of heterologous or homologous muscle and complete Freund's adjuvant. These lesions consist of focal necrosis of muscle fibres with mononuclear inflammatory cell infiltration, resulting in a rise in serum creatine phosphokinase (Esiri & MacLennan 1974) without causing clinical weakness in the animals, and differ obviously in this respect from the human disease.
It is possible to transfer the experimental disease with lymphocytes but not serum (Esiri & MacLennan 1974 ) but again the lesions in recipients are very mild, and this is a drawback of the model. The sensitivity of spleen cells by lymphocyte transformation to autologous skeletal muscle in the animals with myositis has been demonstrated but not significant sensitivity of any other of the lymphocyte populations (Esiri & MacLennan 1975) . Macrophage migration inhibition factor production has also been demonstrated with lymphocytes from rats with myos-itis cultured with skeletal muscle (Manghani et al. 1974) . Lymphocyte cytotoxicity for muscle cultures has been repeatedly demonstrated in this experimental myositis (Kakulas 1966 , Currie et al. 1971 , Sloper et al. 1976 ) as has specific immune adherence of lymphocytes to cultured muscle fibres (Sloper et al. 1976 ).
Myasthenia Gravis
The first studies on an immune mechanism in the pathogenesis of myasthenia gravis were on the possible role of antibody. It was demonstrated that about a third of patients had antibody to striated muscle but the relevance of this was considered very doubtful in view of the fact that the antibody was not directed against any component of the motor end plate but rather was seen by immunofluorescence to be located in the I band of the muscle fibre (Dawkins 1975) . Attempts to demonstrate cell-mediated immunity to skeletal muscle antigens produced conflicting results in contrast to the findings using the same methods in polymyositis. Lymphocyte transformation experiments 4ave failed to demonstrate increased transformation with muscle antigen (Houseley & Oppenheim 1967 , Lisak & Zweiman 1975 , Abramsky et al. 1975 ). Macrophage migration experiments have shown conflicting results, some favouring sensitization of lymphocytes to muscle and thymus (Alpert et al. 1972 , Armstrong et al. 1973 , Goust et al. 1974 ) and another showing no such sensitization (Behan et al. 1975) . Lymphocytes have failed to show evidence of cytotoxicity for cultured skeletal muscle.
It was initially claimed that an experimental model of myasthenia gravis could be produced using the same methods as those used to produce experimental myositis (Goldstein & Whittingham 1966 . Thymic extracts were also claimed to cause development of electromyographic evidence of myasthenia, with or without myositic lesions. These claims have been difficult to substantiate and the significance of this particular model remains doubtful (Dawkins 1975) . It is interesting however to note that we have here a suggestion of overlap in the mechanisms producing both myositis and myasthenia, since in humans there are rare cases of polymyositis and myasthenia gravis occurring together or more often sequentially.
A considerable breakthrough in research on myasthenia gravis was achieved with the isolation of a purified protein from the electric organ of electric fish. This organ basically has the structure of a very large motor end plate and the protein extracted from it consists of the receptor for acetyl choline (ACh) released at the synaptic junction from the presynaptic nerve terminal. With this purified ACh receptor protein it has been possible to demonstrate that patients with myasthenia gravis have circulating lymphocytes that show increased transformation in its presence (Abramsky et al. 1975 ).
Experimental Myasthenia Gravis
The isolation of this ACh receptor protein has enabled a most convincing animal model of myasthenia gravis to be developed (Patrick & Lindstrom 1973 , Heilbronn et al. 1975 , Aharanov et al. 1975 , Green et al. 1975 . Animals injected with the ACh receptor protein together with complete Freund's adjuvant develop fatiguability of their muscles which is obvious clinically and has the same electromyographic features as the human disease. Studies of the motor end plates have shown similar electron microscopic changes to those seen in humans with the disease (Engel 1976 ). Evidence of lymphocyte sensitivity to the ACh receptor protein has been demonstrated in the animal disease (Fuchs et al. 1976) .
The feature of the human disease that does not appear to be reproduced in the animal model of myasthenia is the thymic pathology. It is possible that this takes time to develop, but it is more likely that it is an aspect of the afferent arc of the immunity reflex that results in myasthenia gravis, rather than of the efferent arc that is so effectively reproduced in the model. The precipitating factors that operate either in polymyositis or in myasthenia gravis are not known, and this aspect of the disease is not illuminated by either animal model. Some aspects of the pathology of myasthenia gravis indicate a humorally-mediated disease rather than one mediated primarily by cellular mechanisms but it may be that both responses are necessary either together or sequentially. It seems hopeful that possible interactions between the two can be delineated in this animal model.
